One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

(MedPage Today) — Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort study suggested…

Source link : https://www.medpagetoday.com/ophthalmology/glaucoma/118988

Author :

Publish date : 2025-12-13 13:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Florida Plows Ahead on Push to Roll Back Certain Vaccine Mandates for Schoolchildren

Related Posts

New Endoscopic Method Reduces Pancreatitis

Starting GLP-1s Leads to Healthier Choices at Grocery Store

‘Hospital’s neglect in my son’s death has ripped our hearts out’

Keeping BMD After Taking Osteoanabolics: How Are We Doing?

Darzalex Faspro Quadruplet OK’d for Transplant-Ineligible MM

‘I needed a coil to ease the bleeding but I just sat on a waiting list’

New Endoscopic Method Reduces Pancreatitis

Starting GLP-1s Leads to Healthier Choices at Grocery Store

‘Hospital’s neglect in my son’s death has ripped our hearts out’

Keeping BMD After Taking Osteoanabolics: How Are We Doing?

Darzalex Faspro Quadruplet OK’d for Transplant-Ineligible MM

‘I needed a coil to ease the bleeding but I just sat on a waiting list’

Telesurgery Shows Promise for Radical Prostatectomy, Partial Nephrectomy

CMS Makes Push to Maximize Donor Organs, Even the Imperfect Ones

Categories

Archives